Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Purchase |
2024-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
ORBIMED ADVISORS LLC | 718,200 5.900% |
129,000 (+21.89%) |
Filing History |
| 2024-11-14 7:48 pm Sale |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Point72 Asset Management, L.P. | 0 0.000% |
-388,676 (Position Closed) |
Filing History |
| 2024-11-14 6:41 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
ORBIMED ADVISORS LLC | 589,200 4.900% |
589,200 (New Position) |
Filing History |
| 2024-11-14 4:05 pm Sale |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
K2 HealthVentures Equity Trust LLC | 2,873 0.020% |
-339,240 (-99.16%) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
TANG CAPITAL MANAGEMENT LLC | 600,000 4.980% |
600,000 (New Position) |
Filing History |
| 2024-11-14 3:09 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Cormorant Asset Management LP | 2,375,000 19.500% |
350,000 (+17.28%) |
Filing History |
| 2024-11-12 2:34 pm Unchanged |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
The Vanguard Group | 645,650 5.360% |
0 (Unchanged) |
Filing History |
| 2024-11-12 09:37 am Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Adage Capital Management L.P. | 528,937 4.390% |
528,937 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
BLACKROCK INC BLK |
802,721 6.700% |
0 (Unchanged) |
Filing History |
| 2024-11-04 11:28 am Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
The Vanguard Group | 645,650 5.360% |
645,650 (New Position) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
BLACKROCK INC BLK |
802,721 6.700% |
802,721 (New Position) |
Filing History |
| 2024-10-15 4:19 pm Sale |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
MILLENNIUM MANAGEMENT LLC | 122,751 1.000% |
-421,525 (-77.45%) |
Filing History |
| 2024-10-11 4:02 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Octagon Capital Advisors LP | 1,115,000 9.300% |
1,115,000 (New Position) |
Filing History |
| 2024-03-18 4:11 pm Purchase |
2024-03-08 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Cormorant Asset Management LP | 2,025,000 19.300% |
2,025,000 (New Position) |
Filing History |
| 2024-02-28 4:38 pm Purchase |
2024-02-23 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
MILLENNIUM MANAGEMENT LLC | 544,276 5.300% |
544,276 (New Position) |
Filing History |
| 2024-02-14 4:45 pm Purchase |
2023-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
K2 HealthVentures Equity Trust LLC | 342,113 7.500% |
342,113 (New Position) |
Filing History |
| 2024-02-14 4:41 pm Purchase |
2022-10-25 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% |
10,524,401 (New Position) |
Filing History |
| 2024-02-14 4:08 pm Sale |
2024-01-26 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Paradigm BioCapital Advisors LP | 0 0.000% |
-399,658 (Position Closed) |
Filing History |
| 2024-02-12 4:42 pm Purchase |
2024-02-02 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
ADAGE CAPITAL PARTNERS GP LLC | 796,392 7.700% |
796,392 (New Position) |
Filing History |
| 2024-02-12 4:18 pm Purchase |
2024-02-02 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
RA Capital Management, L.P. | 430,182 4.100% |
430,182 (New Position) |
Filing History |